Search research articles
Contact Us
Filters
Showing results (11-20 of 101) with videos related to
Page
of 11
Sort By:
Plos One
|
April 14, 2016
Joint Modelling of Survival and Emergency Medical Care Usage in Spanish Insureds Aged 65+
Xavier Piulachs, Ramon Alemany, Montserrat Guillen
The Journal of General Virology
|
October 20, 2000
Blood clearance rates of adenovirus type 5 in mice
Ramon Alemany, Kaori Suzuki, David T Curiel
Human Gene Therapy
|
January 20, 2016
Highlights of 8th Biennial Congress of the Spanish Society of Gene and Cell Therapy
Ramon Alemany, Ander Izeta, Javier Garcia-Sancho
Cancers
|
April 29, 2020
Effect of Transgene Location, Transcriptional Control Elements and Transgene Features in Armed Oncolytic Adenoviruses
Martí Farrera-Sal, Cristina Fillat, Ramon Alemany
Methods in Molecular Biology (Clifton, N.J.)
|
October 18, 2013
Oncolytic adenovirus characterization: activity and immune responses
Raul Gil-Hoyos, Juan Miguel-Camacho, Ramon Alemany
Cancer Research
|
September 23, 2003
Ras-dependent oncolysis with an adenovirus VAI mutant
Manel Cascalló, Gabriel Capellà, Adela Mazo, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
August 25, 2011
Adenovirus i-leader truncation bioselected against cancer-associated fibroblasts to overcome tumor stromal barriers
Cristina Puig-Saus, Alena Gros, Ramon Alemany, et al.
Human Gene Therapy
|
March 14, 2009
Antitumor therapy based on cellular competition
Jordi Martinez-Quintanilla, Manel Cascallo, Cristina Fillat, et al.
Cancer Letters
|
March 13, 2008
E2F1 in gliomas: a paradigm of oncogene addiction
Marta M Alonso, Ramon Alemany, Juan Fueyo, et al.
Human Gene Therapy
|
February 7, 2014
Circumventing antivector immunity: potential use of nonhuman adenoviral vectors
Estrella Lopez-Gordo, Iva I Podgorski, Nicholas Downes, et al.
Page
of 11
Search research articles
Search
Showing results (11-20 of 101) with videos related to
Sort By:
Page
of 11
Plos One
|
April 14, 2016
Joint Modelling of Survival and Emergency Medical Care Usage in Spanish Insureds Aged 65+
Xavier Piulachs, Ramon Alemany, Montserrat Guillen
The Journal of General Virology
|
October 20, 2000
Blood clearance rates of adenovirus type 5 in mice
Ramon Alemany, Kaori Suzuki, David T Curiel
Human Gene Therapy
|
January 20, 2016
Highlights of 8th Biennial Congress of the Spanish Society of Gene and Cell Therapy
Ramon Alemany, Ander Izeta, Javier Garcia-Sancho
Cancers
|
April 29, 2020
Effect of Transgene Location, Transcriptional Control Elements and Transgene Features in Armed Oncolytic Adenoviruses
Martí Farrera-Sal, Cristina Fillat, Ramon Alemany
Methods in Molecular Biology (Clifton, N.J.)
|
October 18, 2013
Oncolytic adenovirus characterization: activity and immune responses
Raul Gil-Hoyos, Juan Miguel-Camacho, Ramon Alemany
Cancer Research
|
September 23, 2003
Ras-dependent oncolysis with an adenovirus VAI mutant
Manel Cascalló, Gabriel Capellà, Adela Mazo, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
August 25, 2011
Adenovirus i-leader truncation bioselected against cancer-associated fibroblasts to overcome tumor stromal barriers
Cristina Puig-Saus, Alena Gros, Ramon Alemany, et al.
Human Gene Therapy
|
March 14, 2009
Antitumor therapy based on cellular competition
Jordi Martinez-Quintanilla, Manel Cascallo, Cristina Fillat, et al.
Cancer Letters
|
March 13, 2008
E2F1 in gliomas: a paradigm of oncogene addiction
Marta M Alonso, Ramon Alemany, Juan Fueyo, et al.
Human Gene Therapy
|
February 7, 2014
Circumventing antivector immunity: potential use of nonhuman adenoviral vectors
Estrella Lopez-Gordo, Iva I Podgorski, Nicholas Downes, et al.
Page
of 11